Who Owns the Formula? IP Ownership, Exit Terms and the Cost of Switching Factories

Published: September 7, 2026 | Author: 8OEM Editorial Team | Read time: ~4 minutes

The most expensive sentence in cosmetics is not "we can make it cheaper" — it is "whose formula is this anyway?" IP ownership and exit terms are the two clauses that decide whether your brand can grow, change factories, or survive a bad partnership. Most buyers negotiate price for weeks and leave these two lines to the fine print. That is backwards. Here is what to settle, in writing, before you produce your first batch.

Four IP questions every OEM buyer must answer

Q1 — Who owns the formula?

Three common arrangements, and they are not the same:

• Your formula: you bring the formulation (from your own chemist or a paid consultant). The factory manufactures it. You own it outright. Put this in writing.
• Factory formula, your brand: you select from the factory's existing formula library. The factory owns the formula; you license it for your brand. If you leave, the formula stays. This is normal — but you must know it.
• Co-developed: you and the factory develop together. Without a written split, ownership is a fight. Agree in advance: formula IP, improvement IP, and the right to use the base elsewhere.

Q2 — Who owns the packaging/tooling/molds?

Molds and tooling are physical assets with real cost. Contract should state: who paid for them, who owns them, and what happens on exit. Typical fair terms: buyer-paid tooling belongs to the buyer (or transfers on full payment); factory-paid tooling belongs to the factory. If molds are buyer-owned, you can take them to a new factory — that is your leverage and your exit ticket.

Q3 — What about "improvements"?

If the factory improves "your" formula during development — a better preservative system, a more stable emulsion — who owns the improvement? Standard fair answer: improvements specific to your brand belong to you (or are exclusively licensed to you); generic improvements the factory can offer to any client belong to the factory. Define it, or lose it.

Q4 — What is protected as trade secret vs. documented?

Some buyers protect everything as trade secret; some document formulas with a third party (formulation registration). Decide which strategy fits your brand and make the contract match it. Trade-secret protection depends on confidentiality agreements and access controls; documented protection depends on registration records. Both work — half-measures work for no one.

Exit terms: planning the divorce before the wedding

Exit terms define what happens when the relationship ends — for any reason. Four provisions matter:

1. Formula handover: on termination, the factory transfers all formulation documentation, batch records and specs to you (or your new manufacturer) within a defined window. Without this clause, "your" formula can be held hostage.
2. Tooling transfer: buyer-owned molds/molds paid off must be released and shipped on request, at a defined cost and timeline.
3. Last-batch right: a transition period (typically 3–6 months) during which the factory may produce final runs at agreed terms, so your retail pipeline does not break mid-switch.
4. Non-compete on exit: for a defined period, the factory will not use your specific formula or your registered brand IP for a directly competing line. (See our NNN guide for scope details.)

The real cost of switching factories

Brands underweight switching costs when they sign the first deal:

• Re-stability testing: a new factory must re-run stability and micro programs — 2–3 months and real money.
• Formula transfer reality: even with perfect documentation, a formula behaves differently on different equipment. Expect 1–3 reformulation rounds.
• Packaging re-qualification: new filling lines, new tolerances, potentially new carton specs.
• Compliance re-filing: some markets require notification updates when the manufacturer changes (e.g., EU CPNP).

None of this argues against switching — it argues for negotiating clean exit terms upfront, so that when you switch, you pay the switching cost once, not the hostage cost forever.

The negotiation checklist

1. Write the IP ownership model into the first quotation — not the tenth email.
2. Put mold/tooling ownership and exit transfer in the contract, with timelines.
3. Define "improvements" ownership before co-development starts.
4. Get formula handover + last-batch rights as standard exit terms.
5. If a factory hesitates on any of these four, ask why. The answer tells you how the partnership would end — which is exactly what you are planning for.

The takeaway

Your brand is an asset. Its formula, packaging and exit rights are the deed to that asset. Negotiate them with the same care you give your price per unit — because when the day comes to change factories, only the deed in your hand gets you out the door.

Related 8OEM resources

• Cosmetic OEM & ODM manufacturing — Full-service OEM/ODM: formulation, filling, packaging, export compliance.
• Free sampling & quotation — How sampling, revisions and approval work before mass production.
• Certifications we hold — ISO 22716, FDA-registered facility, and what each certificate actually covers.
• Cosmetics OEM Contract Guide: NDA, NNN, IP Ownership and the Clauses That Protect Your Brand
• NNN Agreements in OEM: What Non-Disclosure, Non-Compete and Non-Circumvention Actually Protect